文献速递胸部CT

Lung-RADS 4X类:能否提高亚实性结节恶性预测

Lung-RADS Category 4X: Does It Improve Prediction of Malignancy in Subsolid Nodules?
PubMed 文献 · Radiology · 2017-03-24

该研究基于国家肺癌筛查试验的374个亚实性结节,由6名胸部放射科医生将15%-24%的结节升级为Lung-RADS 4X类。4X类结节恶性率为46%-57%,明显高于未干预的3类(9%)、4A类(19%)和4B类(23%)。观察者间一致性中等(平均κ=0.535,95%CI:0.509-0.561)。

要点

  • Lung-RADS 4X类结节恶性率46%-57%,高于3类9%、4A类19%、4B类23%。
  • 观察者将15%-24%的亚实性结节升级为4X类,平均假阳性率3类7%、4A类7%、4B类19%。
  • 误升级的良性病变中平均27%为短暂性,短期随访可避免不必要侵入性处理。

核心结论

  • 在结节管理工具中纳入4X评估类别对可疑恶性病变有附加价值,在经验丰富的放射科医生手中可获高恶性率。

研究设计与样本

  • 基于国家肺癌筛查试验基线CT扫描的回顾性分析,纳入374个亚实性结节;6名经验丰富的胸部放射科医生独立判定是否升级为4X类;使用Fleiss κ统计评估观察者间变异性。

诊断标准与关键数值

  • Lung-RADS 4X类为近期引入的类别,用于具有增加恶性怀疑的额外特征或影像表现的病变;观察者升级15%-24%的亚实性结节为4X类;4X类结节恶性率各观察者为46%-57%,未干预的3类、4A类、4B类恶性率分别为9%、19%、23%;4X类平均假阳性率:3类7%、4A类7%、4B类19%;误升级良性病变中平均27%为短暂性;观察者间平均κ=0.535(95%CI:0.509,0.561),一致性中等。

临床应用与阅片要点

  • 作者认为,在结节管理工具中纳入4X评估类别对可疑恶性病变有附加价值;短期随访证明4X类病变的短暂性可避免不必要的侵入性处理。

局限性

  • 观察者间一致性中等,平均κ=0.535(95%CI:0.509,0.561)。
  • 短期随访证明4X类病变的短暂性可避免不必要侵入性处理(原文结论中提出需短期随访验证)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To evaluate the added value of Lung CT Screening Reporting and Data System (Lung-RADS) assessment category 4X over categories 3, 4A, and 4B for differentiating between benign and malignant subsolid nodules (SSNs). Materials and Methods SSNs on all baseline computed tomographic (CT) scans from the National Lung Cancer Trial that would have been classified as Lung-RADS category 3 or higher were identified, resulting in 374 SSNs for analysis. An experienced screening radiologist volumetrically segmented all solid cores and located all malignant SSNs visible on baseline scans. Six experienced chest radiologists independently determined which nodules to upgrade to category 4X, a recently introduced category for lesions that demonstrate additional features or imaging findings that increase the suspicion of malignancy. Malignancy rates of purely size-based categories and category 4X were compared. Furthermore, the false-positive rates of category 4X lesions were calculated and observer variability was assessed by using Fleiss κ statistics. Results The observers upgraded 15%-24% of the SSNs to category 4X. The malignancy rate for 4X nodules varied from 46% to 57% per observer and was substantially higher than the malignancy rates of categories 3, 4A, and 4B SSNs without observer intervention (9%, 19%, and 23%, respectively). On average, the false-positive rate for category 4X nodules was 7% for category 3 SSNs, 7% for category 4A SSNs, and 19% for category 4B SSNs. Of the falsely upgraded benign lesions, on average 27% were transient. The agreement among the observers was moderate, with an average κ value of 0.535 (95% confidence interval: 0.509, 0.561). Conclusion The inclusion of a 4X assessment category for lesions suspicious for malignancy in a nodule management tool is of added value and results in high malignancy rates in the hands of experienced radiologists. Proof of the transient character of category 4X lesions at short-term follow-up could avoid unnecessary invasive management. © RSNA, 2017.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Chung K, Jacobs C, Scholten ET, et al. Lung-RADS Category 4X: Does It Improve Prediction of Malignancy in Subsolid Nodules? Radiology. 2017. PMID: 28339311. doi:10.1148/radiol.2017161624

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。